As the demand for novel therapies and personalized medicine surges, leaders are uniquely positioned to create a culture of creativity, collaboration and innovation.

To avoid a tug-of-war between scientific rigour and operational efficiency, we must focus on the user and data journeys of ...

Chinese Society of Clinical Oncology Breast Cancer (CSCO BC) guidelines mark a significant milestone in breast cancer treatment, seamlessly integrating cutting-edge international research with Chinese ...

A Manchester medtech company has secured new funding to continue scaling its reusable digital device that can track whether ...

Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies designed specifically for patients with ...

Cerebral cavernous malformation (CCM) patients treated with oral drug, REC-994, showed reduction in total cerebral and brainstem lesion volume.

B.well Connected Health, maker of a platform unifying patient data, picked up an additional investment from nonprofit ...

Anavex Life Sciences Corp. (NASDAQ ... 2b/3ATTENTION-AD open-label extension trial. The data demonstrated that over three ...

After 2024, which saw a steady recovery by the life sciences industry, it looks like 2025 is set to be a year of change and ...

Our fundamental challenge is not simply to create the data. Rather, it is to collect and analyze it systematically. Doing so ...